NEW online training courses from DSE. On-demand expert training for educators and parents. Find out more...

Image of Down Syndrome Research and Practice coverDown Syndrome Research and Practice

February, 2009 | Volume 12 | Issue 3

In this issue...

Reviews of the current state of knowledge by leading scientists

Some of the world's leading scientists across all disciplines were brought together by Down Syndrome Education International to review the current state of knowledge in all areas relating to the education and development of people with Down syndrome, and determine future research directions. This issue includes a summary of the proceedings of this symposium, alongside reviews by leading scientists on the Down syndrome phenotype, memory skills, family issues and the use of mouse models to test potential drug therapies.

The use of Ginkgo, Prozac and Focalin as a 'treatment' for Down syndrome

A group of 21 healthcare professionals, scientists and 17 support organizations who care for and about people with Down syndrome around the world have worked together to issue a joint statement on a proposed "treatment" for Down syndrome recently promoted by the Changing Minds Foundation. This 'treatment' involves a combination of drugs recommended for depression and attention deficit and hyperactivity disorder. There is no scientific support for the routine use of this protocol by people who have Down syndrome, and it is important that families and healthcare professionals are aware of the lack of evidence for safety and benefits from use of this protocol.

Contents

Editorial

Statements

Research Highlights

Updates

Practice

Resources

Proceedings

Reviews

Reports

Case studies

New from DSE: See and Learn Speech

See and Learn Speech is designed to help parents and educators support children with Down syndrome to develop clearer speech.

See and Learn Speech offers a structured approach to support speech development, working in small steps towards clearer speech production.

Now available as teaching kits and apps.

Find out more...